Thiazolidinediones and cardiovascular outcomes in type 2 diabetes

被引：6
|
作者：
Singh, Sonal [1 ]
Furberg, Curt D. [2 ]
机构：
[1] Wake Forest Univ, Sch Med, Gen Internal Med Sect, Winston Salem, NC 27157 USA
[2] Wake Forest Univ, Sch Med, Div Publ Hlth Sci, Winston Salem, NC 27157 USA
来源：
HEART | 2009年 / 95卷 / 01期
关键词：
ROSIGLITAZONE; PIOGLITAZONE; MELLITUS; RISK; METAANALYSIS; EVENTS; ASSOCIATION; PREVENTION; STATEMENT; THERAPY;
D O I：
10.1136/hrt.2008.155507
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1 / 3
页数：3
相关论文
共 50 条
  • [41] Cardiovascular Outcomes of New Medications for Type 2 Diabetes
    Trujillo, Jennifer M.
    Wettergreen, Sara A.
    Nuffer, Wesley A.
    Ellis, Samuel L.
    McDermott, Michael T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 (12) : 749 - 758
  • [42] Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes Reply
    Wiviott, Stephen D.
    Raz, Itamar
    Sabatine, Marc S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (19): : 1881 - 1882
  • [43] Dapagliflozin and cardiovascular outcomes in patients with Type 2 diabetes
    Al-Bazz, Dalai Y.
    Wilding, John P. H.
    FUTURE CARDIOLOGY, 2020, 16 (02) : 77 - 88
  • [44] Comment: Thiazolidinediones in Type 2 Diabetes: A Cardiology Perspective
    Musini, Vijaya M.
    Bassett, Kenneth L.
    Tejani, Aaron M.
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (02) : 391 - 392
  • [45] Thiazolidinediones in Type 2 Diabetes MellitusCurrent Clinical Evidence
    Michaela Diamant
    Robert J. Heine
    Drugs, 2003, 63 : 1373 - 1406
  • [46] Editorial: Type 2 diabetes, thiazolidinediones: Bad to the bone?
    Watts, Nelson B.
    D'Alessio, David A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (09): : 3276 - 3278
  • [47] Progress with thiazolidinediones in the management of type 2 diabetes mellitus
    Meriden, T
    CLINICAL THERAPEUTICS, 2004, 26 (02) : 177 - 190
  • [48] Management of type 2 diabetes mellitus - Role of thiazolidinediones
    Noble, J
    Baerlocher, MO
    Silverberg, J
    CANADIAN FAMILY PHYSICIAN, 2005, 51 : 683 - 687
  • [49] Effectiveness and side effects of thiazolidinediones for type 2 diabetes
    Arnold, N
    McLean, M
    Chipps, DR
    Cheung, NW
    MEDICAL JOURNAL OF AUSTRALIA, 2005, 182 (09) : 494 - 494
  • [50] Redefining the role of thiazolidinediones in the management of type 2 diabetes
    Barnett, Anthony H.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2009, 5 : 141 - 151
12345